PAHO selects centers in Argentina, Brazil to develop COVID-19 mRNA vaccines

Washington DC, September 21, 2021 (PAHO) – The Pan American Health Organization (PAHO) has announced the selection of two centers in Argentina and Brazil as regional hubs for the development and production of mRNA-based vaccines in Latin America in a bid to tackle COVID-19 and future infectious-disease challenges.

The Bio-Manguinhos Institute of Technology on Immunobiologicals at the Oswaldo Cruz Foundation (FIOCRUZ) was selected as the center in Brazil. The institute has a long tradition in vaccine manufacturing and has made promising advances in the development of an innovative mRNA vaccine against COVID-19.

Sinergium Biotech, a private sector biopharmaceutical company, was selected as the center in Argentina. Sinergium will partner with pharmaceutical mAbxience, which belongs to the same group, to develop and manufacture active vaccine ingredients. The two companies have extensive experience in the production and development of vaccines and biotechnological medicines.

The announcement was made by Dr. Soumya Swaminathan, World Health Organization (WHO) Chief Scientist, and PAHO Assistant Director Dr Jarbas Barbosa during a side event on the margins of PAHO’s 59th Directing Council. The “Technology Transfer for the Production of mRNA Vaccines in the Americas” event brought together health ministers and authorities from countries in the region to discuss vaccine production.

“We congratulate the two selected centers,” Dr. Jarbas Barbosa said. “There is hard work ahead, but we are driven by the conviction that this endeavor will result in timely and equitable access to vaccines in our region, which continues to be the hardest hit by this pandemic.”

The selection is the result of an April 2021 WHO call for expression of interest inviting manufacturers and research institutions to contribute to the establishment of COVID-19 mRNA vaccine technology transfer hubs in emerging economies. The initiative was supported by PAHO/WHO global partners such as the Medicines Patent Pool.

The call attracted some thirty expressions of interest from Latin American companies and scientific institutions. In order to ensure sustainability and increased regional capacity even further, PAHO launched a second call for expressions of interest in August 2021. This call was particularly aimed at manufacturers that wish to become part of a regional consortium to supply pharmaceutical grade reagents and other inputs for mRNA vaccine production.

PAHO has also recently launched the Regional Platform to Advance the Manufacturing of COVID-19 Vaccines and other Health Technologies in the Americas. The platform will support collaboration across countries and agencies to apply existing regional biomanufacturing capacity to the production of COVID-19 vaccines and other medical technologies. The principle behind the platform is that pharmaceutical manufacture should benefit the entire region, with regional production and distribution of vaccines by PAHO’s Revolving Fund to all countries.

“Delays in production have meant that many countries are still awaiting the doses they purchased months ago. Limited vaccine supplies continue to set us back,” PAHO Director Dr. Carissa F. Etienne said in her opening remarks to the side event. “This limited production and unequal distribution of vaccines in the face of staggering demand hinder our COVID response in the Americas. Mass vaccination is critical,” she added.

The region of the Americas has borne the brunt of COVID-19 infections to date, with 87.6 million cases recorded and over 2.16 million lives lost. Vaccine distribution continues to be unequal, with few countries in the region reaching the 40% COVID-19 vaccine target set out by WHO.

Note: This article have been indexed to our site. We do not claim legitimacy, ownership or copyright of any of the content above. To see the article at original source Click Here

Related Posts
App recognizes suspected mpox rashes using artificial intelligence thumbnail

App recognizes suspected mpox rashes using artificial intelligence

SHAP analysis of the MPXV-CNN. Photographic images of MPXV skin lesions (top) are shown with the corresponding SHAP analysis (bottom) overlaid on the original image to highlight the discriminative image regions used for detection (a–g). The MPXV lesions shown represent different stages as follows: early-stage vesicle (a), small pustule (b), umbilicated pustule (c), papule with
Read More
Malawi launches a national “End Cholera” campaign thumbnail

Malawi launches a national “End Cholera” campaign

Lilongwe – Today the Government of Malawi launched the national Tithetse kolera (End Cholera) campaign to curb the outbreak affecting the country. The campaign was launched by H.E President Dr Lazarus McCarthy Chakwera in Mgona, one of the capital’s cholera hotspots. Prior to the launch, the president visited a cholera treatment centre in Lilongwe area
Read More
50 Delicious Snacks That Are Also Super Healthy thumbnail

50 Delicious Snacks That Are Also Super Healthy

BENEATH ALL THE flashy packaging, many so-called healthy snacks that debuted within the past few years are really just junk. We went on a hunt for high-quality options that actually deliver on muscle-building protein, heart-healthy fats, filling fiber, and flat-out deliciousness.This year we scanned shelves and the Internet for the 20 best new-ish packaged snacks
Read More
MDA-Ihud Hatzalah victims: "Family destroyed due to medical confidentiality" thumbnail

MDA-Ihud Hatzalah victims: “Family destroyed due to medical confidentiality”

יו"ר ועדת הבריאות של הכנסת, ח"כ עידית סילמן, קוראת להפעיל "מוקד אחיד לכלל מוקדי החירום הרפואיים – מד"א, איחוד הצלה ואחרים - שייתן את הפתרון המהיר והמקצועי ביותר הנדרש לאזרחי ישראל". הנושא עלה לדיון אתמול (ד') ובמהלכו נמתחה ביקורת על אופן ניהול מוקדי החירום הרפואי במענה לקריאות עזרה ראשונה. על פי חוזר מנכ"ל משרד הבריאות…
Read More
Nix Race From eGFR, Says Joint Task Force thumbnail

Nix Race From eGFR, Says Joint Task Force

A new equation to estimate kidney function without a race variable is being recommended for use in clinical practice, a joint task force of the National Kidney Foundation (NKF) and the American Society of Nephrology (ASN) reported. Published in both the American Journal of Kidney Diseases and the Journal of the American Society of Nephrology,…
Read More
There is a new variant of R.1, Doctor Tirta Suggests not to worry than to become a Gerd thumbnail

There is a new variant of R.1, Doctor Tirta Suggests not to worry than to become a Gerd

SELAMA persebaran Vaksin Covid-19 belum merata, maka kemungkinan adanya varian baru yang bermutasi akan tetap tinggi. Seperti yang baru-baru ini mendapatkan perhatian, yakni varian R.1 dan Mu.  Mutasi virus corona yang terus berkembang ini mengkhawatirkan masyarakat. Di tengah kekhawatiran tersebut, banyak juga yang bertanya pada dr Tirta, hingga akhirnya dia membuat video penjelasan di akun…
Read More
Index Of News
Consider making some contribution to keep us going. We are donation based team who works to bring the best content to the readers. Every donation matters.
Donate Now

Subscription Form

Liking our Index Of News so far? Would you like to subscribe to receive news updates daily?

Total
0
Share